NDC 37808-022

Fexofenadine HCl and Pseudoephedrine HCI

Fexofenadine Hcl And Pseudoephedrine Hci

Fexofenadine HCl and Pseudoephedrine HCI is a Oral Tablet, Extended Release in the Human Otc Drug category. It is labeled and distributed by Heb. The primary component is Fexofenadine Hydrochloride; Pseudoephedrine Hydrochloride.

Product ID37808-022_8c74b0a5-6bbc-0f8d-bbda-46d6cb39aea6
NDC37808-022
Product TypeHuman Otc Drug
Proprietary NameFexofenadine HCl and Pseudoephedrine HCI
Generic NameFexofenadine Hcl And Pseudoephedrine Hci
Dosage FormTablet, Extended Release
Route of AdministrationORAL
Marketing Start Date2015-12-21
Marketing CategoryANDA / ANDA
Application NumberANDA076667
Labeler NameHEB
Substance NameFEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
Active Ingredient Strength60 mg/1; mg/1
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 37808-022-31

6 BLISTER PACK in 1 CARTON (37808-022-31) > 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Marketing Start Date2015-12-21
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 37808-022-31 [37808002231]

Fexofenadine HCl and Pseudoephedrine HCI TABLET, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076667
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-21

Drug Details

Active Ingredients

IngredientStrength
FEXOFENADINE HYDROCHLORIDE60 mg/1

OpenFDA Data

SPL SET ID:0de7fc37-7f46-4e98-d5ac-d31a3c313a62
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 997406
  • NDC Crossover Matching brand name "Fexofenadine HCl and Pseudoephedrine HCI" or generic name "Fexofenadine Hcl And Pseudoephedrine Hci"

    NDCBrand NameGeneric Name
    0363-0448Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    0363-1606Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    0536-1242Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    11673-032Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    21130-557Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    30142-447Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    30142-611Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    37808-022Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    43598-823Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    49035-273Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    55111-447Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    55111-557Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    59779-508Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    69842-249Fexofenadine HCl and Pseudoephedrine HCIFexofenadine HCl and Pseudoephedrine HCI
    70000-051812HR Allergy and Congestion ReliefFexofenadine HCl and Pseudoephedrine HCI
    11822-7388Allergy and CongestionFexofenadine HCl and Pseudoephedrine HCI
    62011-0455Allergy and CongestionFexofenadine HCl and Pseudoephedrine HCI

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.